Business Description
Mangalam Drugs & Organics Ltd
ISIN : INE584F01014
Compare
Compare
Traded in other countries / regions
MANGALAM.India IPO Date
2005-05-23Description
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | 3.19 | |||||
| Interest Coverage | 0.5 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.16 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9 | |||||
| 3-Year EBITDA Growth Rate | 1.8 | |||||
| 3-Year EPS without NRI Growth Rate | -46.4 | |||||
| 3-Year FCF Growth Rate | -21.1 | |||||
| 3-Year Book Growth Rate | 13.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.41 | |||||
| 9-Day RSI | 54 | |||||
| 14-Day RSI | 50.06 | |||||
| 6-1 Month Momentum % | -0.25 | |||||
| 12-1 Month Momentum % | -10.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.09 | |||||
| Quick Ratio | 0.42 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 105.62 | |||||
| Days Sales Outstanding | 27.26 | |||||
| Days Payable | 78.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.72 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.71 | |||||
| Operating Margin % | 1.5 | |||||
| Net Margin % | -1.8 | |||||
| FCF Margin % | 1.84 | |||||
| ROE % | -7.72 | |||||
| ROA % | -3.05 | |||||
| ROIC % | 3.23 | |||||
| ROC (Joel Greenblatt) % | 2.88 | |||||
| ROCE % | 3.24 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 10.09 | |||||
| Price-to-Owner-Earnings | 10.83 | |||||
| PS Ratio | 0.26 | |||||
| PB Ratio | 1.22 | |||||
| Price-to-Tangible-Book | 1.49 | |||||
| Price-to-Free-Cash-Flow | 13.91 | |||||
| Price-to-Operating-Cash-Flow | 4.09 | |||||
| EV-to-EBIT | 36.81 | |||||
| EV-to-EBITDA | 8.06 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-FCF | 19.51 | |||||
| Price-to-Projected-FCF | 0.8 | |||||
| Price-to-Median-PS-Value | 0.53 | |||||
| Earnings Yield (Greenblatt) % | 2.71 | |||||
| FCF Yield % | 7.28 | |||||
| Forward Rate of Return (Yacktman) % | 12.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mangalam Drugs & Organics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,313.835 | ||
| EPS (TTM) (₹) | -7.168 | ||
| Beta | -0.45 | ||
| Volatility % | 38.1 | ||
| 14-Day RSI | 50.06 | ||
| 14-Day ATR (₹) | 3.909326 | ||
| 20-Day SMA (₹) | 99.5225 | ||
| 12-1 Month Momentum % | -10.88 | ||
| 52-Week Range (₹) | 90.8 - 132.45 | ||
| Shares Outstanding (Mil) | 15.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mangalam Drugs & Organics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mangalam Drugs & Organics Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mangalam Drugs & Organics Ltd Frequently Asked Questions
What is Mangalam Drugs & Organics Ltd(NSE:MANGALAM)'s stock price today?
The current price of NSE:MANGALAM is ₹100.75. The 52 week high of NSE:MANGALAM is ₹132.45 and 52 week low is ₹90.80.
When is next earnings date of Mangalam Drugs & Organics Ltd(NSE:MANGALAM)?
The next earnings date of Mangalam Drugs & Organics Ltd(NSE:MANGALAM) is .
Does Mangalam Drugs & Organics Ltd(NSE:MANGALAM) pay dividends? If so, how much?
Mangalam Drugs & Organics Ltd(NSE:MANGALAM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers